Survival Gains from First‐Line Systemic Therapy in Metastatic Non‐Small Cell Lung Cancer in the U.S., 1990–2015: Progress and Opportunities

BACKGROUND. Approximately 190,000 Americans are diagnosed with non‐small cell lung cancer (NSCLC) annually, and about half have metastatic (Stage IV) disease. These patients have historically had poor survival prognosis, but several new therapies introduced since 2000 provide options for improved ou...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncologist
Main Authors: Roth, Joshua A., Goulart, Bernardo H. L., Ravelo, Arliene, Kolkey, Holli, Ramsey, Scott D.
Format: Artigo
Sprog:Inglês
Udgivet: AlphaMed Press 2017
Fag:
Health Outcomes and Economic of Cancer Care
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5344635/
https://ncbi.nlm.nih.gov/pubmed/28242792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0253
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker